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Background: Greater plaque burden (PB) is a strong predictor for future coronary event. Therefore, patients with large PB need to be 
treated aggressively. It is unknown if patients with large PB equally benefit from statin therapy, compared to those with less PB.
aim: To evaluate statin effects according to the PB in patients with coronary artery disease using optical coherence tomography (OCT).
methods: From a prospective trial (Clinicaltrials.gov number, NCT01023607), we identified 69 patients with 97 lipid-rich plaques who 
were randomized to receive atorvastatin 60mg (AT60), rosuvastatin 10mg (RT10), or atorvastatin 20mg (AT20). PB was measured by 
intravascular ultrasound (IVUS) at baseline. Plaques were divided into two groups: PB > 65% (High PB group: n=57) and PB ≤ 65% (Low 
PB group: n=40). We compared the % change of fibrous cap thickness (%FCT) between the two groups.
results: Both high and low PB groups showed continuous increase in FCT from baseline to 6 and to 12 month (Panel A), but there was no 
significant difference in %FCT between the two groups at 6 month (93.5 vs 126.4 %, P=0.21) and at 12 month (164.0 vs 196.3 %, P=0.27). 
In high PB group, AT60 and RT10 showed significantly greater increase of %FCT at 12month than AT20. In low PB group, there was no 
difference among the three statin groups (Panel B).
Conclusion:  Both high and low PB groups showed increase in FCT after statin therapy. Intensive statin therapy is more beneficial in 
patients with high PB, whereas this difference was less obvious in those with low PB.
